SCHEDULE 13G/A: Citadel Entities and Kenneth Griffin Disclose 5.1% Passive Stake in Arvinas, Inc.
Beneficial Ownership Disclosure
Citadel Advisors LLC, Citadel Securities LLC, and related entities, along with Kenneth Griffin, have disclosed a combined passive beneficial ownership of 5.1% in Arvinas, Inc. common stock.
Summary
- Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC each beneficially own 3,300,630 shares of Arvinas, Inc. common stock, representing 4.8% of the outstanding shares.
- Citadel Securities LLC beneficially owns 112,994 shares, which constitutes 0.2% of the outstanding shares.
- Citadel Securities Group LP and Citadel Securities GP LLC each beneficially own 179,495 shares, representing 0.3% of the outstanding shares.
- Kenneth Griffin, as the ultimate control person, beneficially owns an aggregate of 3,480,125 shares, which represents 5.1% of Arvinas, Inc.'s common stock.
- The reported percentages are based on 68,713,098 shares of Arvinas, Inc. common stock outstanding as of October 25, 2024, as disclosed in the issuer's Form 10-Q filed on October 30, 2024.
- This filing is an Amendment No. 1 to the initial Schedule 13G filed on January 30, 2025, with the primary change being the addition of a Joint Filing Agreement.
- The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Arvinas, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news about the issuer, Arvinas, Inc.
Positives
- The disclosure of a significant 5.1% passive stake by a prominent investment firm like Citadel and its founder Kenneth Griffin may be interpreted by the market as a vote of confidence in Arvinas, Inc.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by Citadel, a major global investment firm, and its founder Kenneth Griffin, in Arvinas, Inc., a biotechnology company. Such disclosures provide transparency regarding large institutional holdings in publicly traded companies, which can sometimes signal investor interest in the sector or specific company.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially influencing investor sentiment due to the involvement of a prominent firm like Citadel.
- Company Management: Awareness of a significant passive shareholder, though the filing explicitly states the stake is not for control influence.
Key Dates
| Date | Description |
|---|---|
| 2024-10-25 | Date of shares outstanding calculation (68,713,098 shares) based on issuer's Form 10-Q. |
| 2024-10-30 | Date Arvinas, Inc. filed its Form 10-Q, which provided the shares outstanding figure. |
| 2025-01-23 | Date of event which requires filing of this statement. |
| 2025-01-30 | Date the initial Schedule 13G was filed. |
| 2025-02-14 | Date of signing and filing of this Amendment No. 1 to Schedule 13G. |
Keywords
Arvinas Inc., Citadel Advisors, Citadel Securities, Kenneth Griffin, Schedule 13G, beneficial ownership, common stock, passive investment, institutional ownership, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.